Home▸Articles▸Hepatology & Liver Disease Modeling

NAFLD/NASH Fibrosis Progression: From Fat Accumulation to Liver Scarring

Understanding the progression of non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), is crucial for effective treatment strategies.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What Is NAFLD/NASH?

Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of fat in the liver cells, known as hepatocytes. When this fat accumulation progresses to inflammation and scarring, it becomes non-alcoholic steatohepatitis (NASH).

The progression from NAFLD to NASH involves a series of pathological changes that can ultimately lead to cirrhosis, a condition where healthy liver tissue is replaced by scar tissue, significantly impairing the organ's function.

Pathophysiology of NAFLD/NASH

The primary driver of NAFLD and NASH is insulin resistance, which leads to increased hepatic triglyceride synthesis. This results in fat accumulation within hepatocytes, leading to inflammation and oxidative stress.

Inflammation triggers the activation of liver stellate cells (LSCs), which transform into myofibroblasts and produce excessive extracellular matrix proteins, contributing to fibrosis.

live demo · related simulation● LIVE

Stages of Fibrosis

Fibrosis in NAFLD/NASH progresses through several stages: simple steatosis (fat accumulation), inflammation, early fibrosis, advanced fibrosis, and cirrhosis. Each stage is characterized by increasing levels of liver damage and scarring.

Advanced fibrosis can lead to portal hypertension, hepatocellular carcinoma, and eventually liver failure.

Clinical Implications

Early detection and management of NAFLD/NASH are critical to prevent progression to more severe stages. Lifestyle modifications such as weight loss, dietary changes, and increased physical activity can significantly improve outcomes.

In advanced cases, liver transplantation may be necessary.

Frequently asked questions

What causes NAFLD/NASH?

NAFLD is primarily caused by insulin resistance and obesity. NASH develops when fat accumulation in the liver leads to inflammation and scarring, often due to metabolic factors such as high triglyceride levels and chronic low-grade inflammation.

Can NAFLD/NASH be reversed?

In early stages of NAFLD, lifestyle changes can reverse fat accumulation. However, once NASH develops, fibrosis is more difficult to reverse, although it may slow down or halt progression with appropriate interventions.

How is NAFLD/NASH diagnosed?

NAFLD/NASH is often diagnosed through a combination of blood tests, imaging techniques like ultrasound or MRI, and liver biopsy. Liver function tests can indicate inflammation or damage, while imaging helps assess the extent of fat accumulation.

What are the risk factors for NAFLD/NASH?

Risk factors include obesity, type 2 diabetes, high triglyceride levels, metabolic syndrome, and a sedentary lifestyle. Genetics also play a role in predisposing individuals to these conditions.

Try it live

Everything above runs in your browser — open NAFLD/NASH Fibrosis Progression and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open NAFLD/NASH Fibrosis Progression simulation

What did you find?

Add reproduction steps (optional)